Profil Disolusi Terbanding, Penetapan Kadar, dan Kualitas Fisik Tablet Atorvastatin Inovator, Generik Bernama Dagang, dan Generik
Downloads
Downloads
Brunton L, Parker K, Blumenthal D, Buxton I, editors. Terapi obat untuk hiperkolesterolemia dan dislipidemia, dalam Goodman & Gilman: Manual farmakologi dan terapi. Jakarta: Penerbit Buku Kedokteran EGC; 2010.
Van der Most PJ, Dolga AM, Nijholt IM, Luiten PGM, Eisel ULM. Statins: Mechanisms of neuroprotection. Prog Neurobiol [Internet]. 2009 [cited 2013 Oct 29];88(1):64–75. Available from: http://www.sciencedirect.com/science/article/pii/S0301008209000318
Smilde TJ, van Wissen S, Wollersheim H, Trip MD, Kastelein JJ, Stalenhoef a F. Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hyper-cholesterolaemia (ASAP): a prospective, randomised, double-blind trial. Lancet [Internet]. 2001 Feb 24;357(9256):577–81. Available from: http://www.ncbi. nlm.nih.gov/pubmed/11558482
Farnier M, Portal JJ, Maigret P. Efficacy of atorvastatin compared with simvastatin in patients with hypercholesterolemia. J Cardiovasc Pharmacol Ther. 2000;5(1):27–32.
Harper M, Kang P. The world’s ten best selling drugs [Internet]. Available from: www.forbes.com
Bartholow M. Top 200 drugs of 2010 [Internet]. Available from: www. pharmacytimes.com
Top 100 drugs for 2011 [Internet]. Available from: www.drugs.com
Badan POM RI. Peraturan Kepala Badan POM RI No. HK.03.1.23.10.11.08481 tahun 2011 tentang Kriteria dan Tata Laksana Registrasi Obat. Jakarta: Badan POM RI; 2011.
Peraturan Menteri Kesehatan Republik Indonesia No. HK.02.02/MENKES/068/
tentang Kewajiban Menggunakan Obat Generik di Fasilitas Pelayanan Kesehatan Pemerintah. Jakarta: Kementerian Kesehatan Republik Indonesia; 2010.
Yunarto N. Revitalisasi obat generik: hasil uji disolusi obat generik tidak kalah dengan obat bermerk. Media Penelit dan Pengemb Kesehat. 2010;20(4):198–202.
Popy FA, Dewan I, Parvin N, Islam SMA. Evaluation of in vitro equivalence for tablets containing the poorly water-soluble compound atorvastatin. Dissolution Technol. 2012;30–3.
Cardot J, Beyssac E, Alric M. In vitro–in vivo correlation: importance of dis-solution in IVIVC. Dissolution Technol. 2007;15–9.
Oishi TS, Nimmi I, Islam SMA. Comparative in vitro bioequivalence analysis of some generic tablets of atorvastatin, a BCS class II compound. Bangladesh Pharm J. 2011;14(1):61–6.
Allen L V, Popovich NG, Ansel HC. Ansel’s pharmaceutical dosage forms and drug delivery systems. 9th ed. Troy DB, editor. Philladelphia: Lippincott Williams & Wilkins; 2011.
The United States Pharmacopeial Convention. The United States Pharmacopeia-National Formulary. 34th ed. Maryland: The United States Pharmacopeia Convention; 2011.
Farmakope Indonesia III. Jakarta: Departemen Kesehatan RI; 1979.
Food and Drug Administration. FDA dissolution methods for drug products [Internet]. Available from: http://www.
accessdata.fda.gov/scripts/cder/dissolution/dsp_SearchResults_Dissolutions.cfm
Food and Drug Administration. Guidance for industry: dissolution testing of immediate release solid oral dosage forms [Internet]. 1997. Available from: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm070237.pdf
Krämer J. Establishing a relationship between disintegration and dissolution [Internet]. 2009 [cited 2014 Dec 18]. Available from: https://www.aaps.org/ uploadedFiles/Content/Sections_and_Groups/Focus_Groups/KramerSA2.pdf
Brunton LL, Parker KL, Blumenthal DK, Buxton ILO, editors. Goodman & Gilman: manual farmakologi dan terapi. Jakarta: EGC; 2010.
Jones D. Fasttrack pharmaceutics: Dosage form and design. London: Pharmaceutical Press; 2008.
Augsburger L, Hoag S, editors. Pharmaceutical Dosage Forms - Tablets Volume 1 [Internet]. 3rd ed. New York: Informa Healthcare; 2008. Available from:http://www.crcnetbase.com/isbn/9781420025989
De Oliveira MA, Lacerda CD, Bonella AF. Developing methods to compare tablet formulations of atorvastatin. Brazillian J Pharm Sci [Internet]. 2012;48(4):801–10. Available from: http://www.scielo.br/pdf/bjps/v48n4/v48n4a24.pdf
Hasson K. Enhancement of atorvastatin tablet dissolution using acid medium introduction. Iraqi J Pharm Sci. 2010;19(1):82–5.
Akinleye MO, Idris O, Nwachukwu PN, Oyetunde OO. Quality of brands of atorvastatin calcium tablets marketed in Lagos, Nigeria. Int J Pharm Pharmacol. 2012;1(1):1–7.
